To beat China in the lab, America’s edge is trust not speed

The United States is right to worry about losing ground to China in clinical research. But if Washington frames trial reform mainly as a race, it risks missing the larger prize: a faster, safer and more trusted model for developing medicines that the rest of the world can rely. The Food and Drug Administration’s (FDA)
The post To beat China in the lab, America’s edge is trust not speed appeared first on Asia Times.Asia TimesRead More